secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001628280-22-017354
Event type: dividend
Sentiment:  positive
Materiality: 0.80
Item codes: 5.07, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast declares $1.64 quarterly dividend, reelects directors, and amends executive severance plan
--------------------------------------------------------------------------------

- Stockholders elected seven directors to Medifast's board, each receiving over 8.8 million votes for.
- Stockholders ratified RSM US LLP as independent auditor for 2022 with over 10 million votes in favor.
- Non-binding advisory vote on executive compensation passed with 8.6 million votes for.
- Board amended Executive Severance Plan, increasing severance multiples to 1.5x salary (2.5x for CEO) plus target bonus on change in control.
- Declared $1.64 per share quarterly dividend payable on August 8, 2022 to shareholders of record June 28, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828022017354/0001628280-22-017354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828022017354/med-20220615.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-017354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer